The plasma trade is becoming ever-more hypocritical
Reliance on America grows, as other countries clutch their pearls
An unusual sort of business will soon open in Shelby, North Carolina. It will take over premises previously run by a flooring company, tucked in beside shops selling clothes, paint and fast food. But it will not sell anything itself. Instead, willing donors, paid around $40 a pop, will sit connected to an apheresis machine. Over the course of an hour, the machine will extract their blood, siphon out plasma and recirculate the remaining fluid. The plasma will then be made into medicines, such as clotting factors for haemophiliacs and intravenous immunoglobulins for those suffering from autoimmune diseases.
Explore more
This article appeared in the Finance & economics section of the print edition under the headline “Blood boom”
Finance & economics August 31st 2024
- Inflation is down and a recession is unlikely. What went right?
- Are American rents rigged by algorithms?
- The plasma trade is becoming ever-more hypocritical
- How Vladimir Putin hopes to transform Russian trade
- Can Japan’s zombie bond market be brought back to life?
- Vast government debts are riskier than they appear
More from Finance & economics
China meets its official growth target. Not everyone is convinced
For one thing, 2024 saw the second-weakest rise in nominal GDP since the 1970s
Ethiopia gets a stockmarket. Now it just needs some firms to list
The country is no longer the most populous without a bourse
Are big cities overrated?
New economic research suggests so
Why catastrophe bonds are failing to cover disaster damage
The innovative form of insurance is reaching its limits
“The Traitors”, a reality TV show, offers a useful economics lesson
It is a finite, sequential, incomplete information game
Will Donald Trump unleash Wall Street?
Bankers have plenty of reason to be hopeful